Atossa Therapeutics
ATOS
#10042
Rank
HK$0.32 B
Marketcap
HK$37.44
Share price
-1.44%
Change (1 day)
388.46%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2025 (TTM): -HK$1.95

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$1.96. In 2024 the company made an earnings per share (EPS) of -HK$1.57 an increase over its 2023 EPS that were of -HK$1.88.

EPS history for Atossa Therapeutics from 2010 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$1.9524.46%
2024-HK$1.57-16.67%
2023-HK$1.8814.29%
2022-HK$1.6416.67%
2021-HK$1.41-90.86%
2020-HK$15.43-2.96%
2019-HK$15.90-63.09%
2018-HK$43.08-49.63%
2017-HK$85.53-57.87%
2016-HK$203.02-74.01%
2015-HK$781.07-9.18%
2014-HK$860.01-12.86%
2013-HK$986.9070.73%
2012-HK$578.0434.08%
2011-HK$431.13263.47%
2010-HK$118.61

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$68.43-3,594.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
HK$71.82-3,768.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
HK$88.98-4,644.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
-HK$4.86 148.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
-HK$1.64-16.00%๐Ÿ‡บ๐Ÿ‡ธ USA